• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Highlander Partners Announces the Acquisition of Ares, the Leading Private Interventional Cardiology Provider in Romania

Share:

July 8, 2019

Highlander Partners (PRNewsFoto/Highlander Partners, L.P.)

Highlander Partners L.P., a leading middle market private investment firm based in Dallas, Texas, today announced the acquisition of the majority stake in the Ares Group (“Ares”). Founded in 2013 and headquartered in Bucharest, Ares is the leading private provider of interventional cardiology procedures in Romania, with 5 facilities today. Its medical team is composed of highly reputable interventional cardiologists and key opinion leaders from Romania and throughout Europe.

The founders of the business, Oren Iancovici and Iulian Plescan, will continue to serve in their Chief Executive Officer and Chief Development Officer roles, respectively. In partnership with Dr. Iancovici, Mr. Plescan and the rest of the existing Ares team, Highlander intends to accelerate growth by introducing new facilities around the country while also enhancing capabilities at existing Ares facilities. These efforts should significantly increase access to high-end interventional cardiology care for patients across Romania, which is currently limited.

Dr. Oren Iancovici, CEO and Founder of Ares, commented, “We believe that together with our new partners we will be strongly prepared to bring the business to the next level and expand our services to the entire country, while continuing to innovate in the field of endovascular medicine in Romania. Given the Highlander team’s extensive medical services investment expertise, we are convinced that we will have both a strong financial and strategic partner.”

Ben Slater, Director of Highlander Partners and Head of Highlander’s Romanian efforts, added, “We have spent two years assessing a variety of opportunities in Romania and are extremely pleased to announce our first investment in the country. Ares possesses all the qualities that we have been seeking. It is a market leading business led by an exceptional management team, participating in a space – private pay healthcare – that will become increasingly demanded as the Romanian economy continues to develop.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Jeff Hull, President and CEO of Highlander Partners, added, “We are excited to combine Ares’ visionary founders with our local team, which has previously been deeply involved in several successful healthcare investments in Romania. We see tremendous growth potential in Ares and are equally motivated by its social impact.”

RTPR Allen & Overy acted as legal counsel of Highlander Partners and TS Partners as financial and tax advisor, while Toacse, Iavolschi & Associates acted as a legal counsel and Contradiction as financial advisor to Centrele de Excelenta Ares.

Date: July 08, 2019

Source: Highlander Partners

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Fittrack Launches Beebo, a Smart Scale for Moms-to-beFittrack Launches Beebo, a Smart Scale for Moms-to-be
  • Modernizing Data Access: 3 Tips for Securing Patient Data in the CloudModernizing Data Access: 3 Tips for Securing Patient Data in the Cloud
  • Turbine Secures €3 Million EUR Seed Fund to Expand the Potential of Simulation-first Drug DiscoveryTurbine Secures €3 Million EUR Seed Fund to Expand the Potential of Simulation-first Drug Discovery
  • Parexel announces new wearable, mobile tech for clinical trialsParexel announces new wearable, mobile tech for clinical trials
  • HealthLynked Closes Acquisition of Cura Health Management, LLC and ACO Health PartnersHealthLynked Closes Acquisition of Cura Health Management, LLC and ACO Health Partners
  • Worldwide Industry for Pharmaceuticals Contract Development & Manufacturing to 2025Worldwide Industry for Pharmaceuticals Contract Development & Manufacturing to 2025
  • Walmart Looks to Virtual Care with Acquisition of Telemedicine Company MeMDWalmart Looks to Virtual Care with Acquisition of Telemedicine Company MeMD
  • Babylon reports revenue growth amid reverse share split and more digital health earningsBabylon reports revenue growth amid reverse share split and more digital health earnings

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications